ENTECAVIR

ENTECAVIR was reported 11801 times

ENTECAVIR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GENOTYPE DRUG RESISTANCE TEST 30 0.6122
1 BLOOD HIV RNA DECREASED 22 0.6111
2 PAROTID GLAND HAEMORRHAGE 6 0.4615
3 HEPATITIS B DNA INCREASED 144 0.2136
4 HEPATITIS B E ANTIGEN POSITIVE 7 0.1667
5 ANTIVIRAL DRUG LEVEL BELOW THERAPEUTIC 6 0.1622
6 ACQUIRED AMINOACIDURIA 5 0.1220
7 HIV ASSOCIATED NEPHROPATHY 6 0.1176
8 RENAL GLYCOSURIA 7 0.1029
9 HEPATITIS B DNA ASSAY POSITIVE 11 0.0859
10 HEPATITIS D 6 0.0714
11 HEPATITIS B SURFACE ANTIGEN POSITIVE 19 0.0693
12 PULMONARY MICROEMBOLI 6 0.0594
13 CHRONIC HEPATITIS B 18 0.0568
14 HEPATITIS B 332 0.0550
15 PORTAL VEIN OCCLUSION 8 0.0548
16 EXPOSURE VIA BODY FLUID 43 0.0547
17 HEPATITIS B REACTIVATION 170 0.0535
18 ACUTE HEPATITIS B 17 0.0512
19 HEPATIC NEOPLASM MALIGNANT 107 0.0505
20 GENOTYPE DRUG RESISTANCE TEST POSITIVE 47 0.0457
21 OSTEOMALACIA 64 0.0414
22 FANCONI SYNDROME ACQUIRED 70 0.0398
23 SPECIFIC GRAVITY URINE DECREASED 6 0.0390
24 HYPOURICAEMIA 11 0.0379
25 VIRAL MUTATION IDENTIFIED 132 0.0358
26 HYPOPHOSPHATAEMIC OSTEOMALACIA 9 0.0341
27 VIRAL LOAD INCREASED 127 0.0327
28 FANCONI SYNDROME 45 0.0318
29 AMINOACIDURIA 5 0.0314
30 ALPHA 1 FOETOPROTEIN INCREASED 22 0.0309
31 BETA 2 MICROGLOBULIN INCREASED 8 0.0307
32 RETINOPATHY HYPERTENSIVE 9 0.0297
33 MONKEYPOX 8 0.0290
34 HEPATOCELLULAR CARCINOMA 216 0.0284
35 MITOCHONDRIAL MYOPATHY 6 0.0275
36 THERAPEUTIC EMBOLISATION 8 0.0256
37 HEPATECTOMY 8 0.0256
38 HEPATITIS B VIRUS TEST POSITIVE 9 0.0236
39 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES 6 0.0205
40 RETINAL DEPIGMENTATION 6 0.0196
41 HEPATITIS B CORE ANTIBODY POSITIVE 7 0.0186
42 MULTIPLE-DRUG RESISTANCE 57 0.0184
43 HYPOPROTEINAEMIA 34 0.0179
44 HYPOPHOSPHATAEMIA 129 0.0174
45 PATHOGEN RESISTANCE 146 0.0160
46 DRUG RESISTANCE 407 0.0158
47 GASTRIC VARICES HAEMORRHAGE 5 0.0152
48 DISSEMINATED CRYPTOCOCCOSIS 11 0.0145
49 FOETAL HYPOKINESIA 10 0.0143
50 VASCULAR STENT STENOSIS 6 0.0143
51 BLOOD PHOSPHORUS DECREASED 51 0.0139
52 OESOPHAGEAL VARICES HAEMORRHAGE 30 0.0138
53 BILIARY TRACT INFECTION 8 0.0129
54 MYCOPLASMA INFECTION 10 0.0128
55 CRYOGLOBULINAEMIA 9 0.0126
56 HEPATORENAL SYNDROME 21 0.0124
57 COMA HEPATIC 9 0.0121
58 FOETAL HEART RATE ABNORMAL 11 0.0119
59 CANCER SURGERY 11 0.0115
60 HEPATIC ENCEPHALOPATHY 107 0.0115
61 RENAL TUBULAR ATROPHY 10 0.0113
62 PORTAL VEIN THROMBOSIS 36 0.0111
63 NODULAR REGENERATIVE HYPERPLASIA 7 0.0109
64 GASTRIC VARICES 5 0.0106
65 LIVER TRANSPLANT 38 0.0104
66 OPTIC NEUROPATHY 22 0.0104
67 BLOOD URIC ACID DECREASED 5 0.0103
68 MENINGITIS CRYPTOCOCCAL 18 0.0103
69 EPISCLERITIS 7 0.0101
70 LIVER TRANSPLANT REJECTION 18 0.0100
71 MEAN PLATELET VOLUME INCREASED 6 0.0099
72 RENAL TUBULAR INJURY 12 0.0099
73 ALANINE AMINOTRANSFERASE DECREASED 7 0.0097
74 STARVATION 8 0.0096
75 NEONATAL RESPIRATORY DISTRESS 9 0.0095
76 GASTRIC ANTRAL VASCULAR ECTASIA 5 0.0095
77 VIRAEMIA 13 0.0094
78 CHONDROCALCINOSIS 6 0.0092
79 TESTICULAR ATROPHY 8 0.0092
80 PREGNANCY ON CONTRACEPTIVE 13 0.0089
81 RETINAL TOXICITY 9 0.0087
82 HERPES ZOSTER DISSEMINATED 7 0.0087
83 ARACHNOIDITIS 6 0.0087
84 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 8 0.0084
85 CAMPYLOBACTER GASTROENTERITIS 5 0.0084
86 BLOOD ALKALINE PHOSPHATASE DECREASED 8 0.0084
87 KLEBSIELLA BACTERAEMIA 8 0.0084
88 PNEUMONIA INFLUENZAL 10 0.0084
89 HEPATIC CIRRHOSIS 156 0.0083
90 BLOOD BILIRUBIN UNCONJUGATED INCREASED 6 0.0083
91 SYPHILIS 6 0.0083
92 RENAL TUBULAR ACIDOSIS 18 0.0082
93 KLEBSIELLA SEPSIS 9 0.0080
94 CRYPTOCOCCOSIS 13 0.0080
95 HEPATIC FAILURE 233 0.0077
96 HYPOALBUMINAEMIA 59 0.0076
97 AUTOIMMUNE HAEMOLYTIC ANAEMIA 26 0.0076
98 HEPATIC FIBROSIS 26 0.0076
99 ADENOCARCINOMA GASTRIC 7 0.0075
100 VARICES OESOPHAGEAL 22 0.0073
101 FUNGAL SEPSIS 6 0.0072
102 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 12 0.0072
103 HEPATIC NEOPLASM 23 0.0070
104 MIXED LIVER INJURY 21 0.0070
105 ILEAL ULCER 7 0.0069
106 RENAL TUBULAR DISORDER 19 0.0067
107 CREATININE RENAL CLEARANCE INCREASED 5 0.0067
108 GLYCOSURIA 9 0.0067
109 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 22 0.0067
110 SYSTEMIC INFECTION 11 0.0066
111 PROTEIN URINE 6 0.0066
112 CHOLANGITIS ACUTE 5 0.0066
113 IMMUNE-MEDIATED LUNG DISEASE 12 0.0066
114 LIVER ABSCESS 21 0.0065
115 BLOOD CHLORIDE INCREASED 11 0.0064
116 IMMUNE-MEDIATED HEPATITIS 13 0.0064
117 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 8 0.0063
118 ABORTION INDUCED 58 0.0062
119 CYTOMEGALOVIRUS CHORIORETINITIS 12 0.0061
120 EXPOSURE VIA FATHER 8 0.0061
121 PACKED RED BLOOD CELL TRANSFUSION 8 0.0060
122 CHOLANGIOCARCINOMA 9 0.0060
123 BILIRUBIN CONJUGATED INCREASED 14 0.0060
124 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 14 0.0060
125 FEBRILE INFECTION 7 0.0059
126 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 13 0.0059
127 HYPERURICAEMIA 24 0.0058
128 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 7 0.0058
129 BLOOD BICARBONATE DECREASED 11 0.0058
130 HEPATITIS E 9 0.0057
131 CYTOMEGALOVIRUS INFECTION REACTIVATION 25 0.0057
132 POLYOMAVIRUS VIRAEMIA 6 0.0056
133 TRANSPLANT DYSFUNCTION 10 0.0056
134 VIROLOGIC FAILURE 30 0.0056
135 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 8 0.0056
136 OBSTRUCTION GASTRIC 7 0.0054
137 ASCITES 158 0.0054
138 ELECTROCARDIOGRAM CHANGE 5 0.0053
139 BLOOD FIBRINOGEN DECREASED 6 0.0053
140 SPLENECTOMY 6 0.0052
141 HYPOCHLORAEMIA 6 0.0051
142 LYMPHOCYTE COUNT DECREASED 86 0.0049
143 SUSPECTED COUNTERFEIT PRODUCT 19 0.0048
144 RENAL TRANSPLANT 17 0.0047
145 BLOOD AMYLASE INCREASED 8 0.0047
146 HEPATIC CANCER 112 0.0047
147 PROTEIN URINE PRESENT 23 0.0046
148 PARAINFLUENZAE VIRUS INFECTION 7 0.0046
149 PYELONEPHRITIS ACUTE 9 0.0046
150 GENE MUTATION 9 0.0045
151 MEAN CELL VOLUME DECREASED 7 0.0045
152 CELL DEATH 9 0.0045
153 CYTOMEGALOVIRUS TEST POSITIVE 8 0.0045
154 BLOOD HIV RNA INCREASED 8 0.0044
155 HEPATITIS FULMINANT 13 0.0044
156 ACUTE LEUKAEMIA 7 0.0043
157 METABOLIC ENCEPHALOPATHY 13 0.0043
158 CHRONIC SPONTANEOUS URTICARIA 5 0.0043
159 HEPATIC FUNCTION ABNORMAL 161 0.0043
160 BLOOD CREATINE INCREASED 19 0.0043
161 CREATININE RENAL CLEARANCE DECREASED 17 0.0042
162 BLOOD BILIRUBIN INCREASED 113 0.0042
163 BILE DUCT STENOSIS 5 0.0042
164 BLOOD URIC ACID INCREASED 24 0.0042
165 FIXED ERUPTION 7 0.0041
166 VENOOCCLUSIVE LIVER DISEASE 20 0.0040
167 KIDNEY FIBROSIS 7 0.0040
168 FRACTURED SACRUM 5 0.0040
169 GASTROINTESTINAL TUBE INSERTION 10 0.0040
170 CHRONIC GASTRITIS 9 0.0040
171 PROTEINURIA 75 0.0039
172 ABORTION MISSED 5 0.0039
173 ACUTE HEPATIC FAILURE 53 0.0039
174 ENCEPHALITIS AUTOIMMUNE 5 0.0038
175 NEUTROPHIL COUNT DECREASED 154 0.0038
176 LYMPHOCYTOSIS 8 0.0037
177 OCULAR ICTERUS 16 0.0037
178 LUNG ADENOCARCINOMA 11 0.0037
179 LIPASE INCREASED 28 0.0037
180 BLOOD PRESSURE SYSTOLIC ABNORMAL 9 0.0036
181 HEPATIC MASS 7 0.0036
182 SEBORRHOEIC DERMATITIS 6 0.0036
183 BLOOD LACTIC ACID INCREASED 19 0.0036
184 NEPHROPATHY TOXIC 39 0.0035
185 ALANINE AMINOTRANSFERASE INCREASED 213 0.0035
186 HYPOPITUITARISM 6 0.0034
187 CARDIAC FAILURE ACUTE 22 0.0033
188 GLOMERULONEPHRITIS 8 0.0033
189 BK VIRUS INFECTION 11 0.0033
190 AMYLASE INCREASED 12 0.0032
191 OTOTOXICITY 6 0.0032
192 PORTAL HYPERTENSION 10 0.0032
193 JAUNDICE 87 0.0032
194 PSYCHOMOTOR RETARDATION 9 0.0032
195 STEM CELL TRANSPLANT 8 0.0032
196 HYPERAMMONAEMIA 16 0.0032
197 NOSOCOMIAL INFECTION 7 0.0032
198 BLOOD ALKALINE PHOSPHATASE INCREASED 78 0.0031
199 NORMAL NEWBORN 17 0.0031
200 HYPOCALCAEMIA 59 0.0031
201 RHEUMATIC DISORDER 6 0.0031
202 TRANSAMINASES INCREASED 69 0.0031
203 CYTOKINE RELEASE SYNDROME 62 0.0031
204 ABORTION 9 0.0031
205 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 23 0.0031
206 BLOOD CREATINE PHOSPHOKINASE INCREASED 88 0.0031
207 FEBRILE NEUTROPENIA 202 0.0030
208 HEPATIC PAIN 13 0.0030
209 HAEMOLYTIC ANAEMIA 27 0.0030
210 HYPOKALAEMIA 139 0.0030
211 GLOMERULAR FILTRATION RATE DECREASED 37 0.0030
212 HYPERLACTACIDAEMIA 8 0.0030
213 DRUG TOLERANCE 15 0.0030
214 COVID-19 PNEUMONIA 35 0.0030
215 BACTERAEMIA 35 0.0029
216 INTRA-ABDOMINAL HAEMORRHAGE 7 0.0029
217 HYPERPARATHYROIDISM 6 0.0029
218 BENIGN PROSTATIC HYPERPLASIA 15 0.0029
219 DIFFUSE LARGE B-CELL LYMPHOMA 22 0.0029
220 AGRANULOCYTOSIS 53 0.0028
221 IMMUNE THROMBOCYTOPENIA 13 0.0028
222 PLATELET COUNT DECREASED 302 0.0028
223 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 6 0.0028
224 RENAL IMPAIRMENT 236 0.0028
225 HYPERBILIRUBINAEMIA 29 0.0028
226 HYPERPHOSPHATAEMIA 6 0.0028
227 TRANSPLANT REJECTION 22 0.0027
228 ABDOMINAL INFECTION 7 0.0027
229 ASPARTATE AMINOTRANSFERASE INCREASED 144 0.0027
230 CYTOMEGALOVIRUS INFECTION 45 0.0027
231 PNEUMOCYSTIS JIROVECI PNEUMONIA 6 0.0027
232 ADENOCARCINOMA OF COLON 5 0.0027
233 BLOOD LACTATE DEHYDROGENASE INCREASED 42 0.0026
234 B-CELL LYMPHOMA 9 0.0026
235 COMPLICATIONS OF TRANSPLANTED KIDNEY 6 0.0026
236 BILE DUCT OBSTRUCTION 5 0.0026
237 APLASIA PURE RED CELL 9 0.0026
238 PNEUMONIA BACTERIAL 24 0.0026
239 RECTAL CANCER 8 0.0026
240 METASTASES TO LUNG 30 0.0026
241 ADRENOCORTICAL INSUFFICIENCY ACUTE 5 0.0026
242 YELLOW SKIN 12 0.0026
243 JAUNDICE CHOLESTATIC 9 0.0025
244 PNEUMOCYSTIS JIROVECII PNEUMONIA 25 0.0025
245 BLOOD CREATININE INCREASED 162 0.0025
246 SPLENOMEGALY 29 0.0025
247 SEPTIC SHOCK 107 0.0025
248 IMMUNE-MEDIATED ENTEROCOLITIS 9 0.0024
249 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 57 0.0024
250 MYOPATHY 21 0.0024
251 ESCHERICHIA SEPSIS 7 0.0024
252 NEPHRITIS 8 0.0024
253 BLOOD ALBUMIN DECREASED 19 0.0024
254 HYPERPARATHYROIDISM SECONDARY 6 0.0024
255 AUTOIMMUNE THYROIDITIS 9 0.0024
256 HIV INFECTION 7 0.0023
257 BRONCHOPULMONARY ASPERGILLOSIS 18 0.0023
258 HEPATITIS 59 0.0023
259 AUTOIMMUNE HEPATITIS 16 0.0023
260 CHOLESTASIS 44 0.0023
261 LIVER DISORDER 101 0.0023
262 TUMOUR LYSIS SYNDROME 20 0.0023
263 DEPRESSIVE SYMPTOM 8 0.0023
264 BLOOD CREATININE DECREASED 7 0.0022
265 DRUG-INDUCED LIVER INJURY 69 0.0022
266 VIRAL INFECTION 73 0.0022
267 LACTIC ACIDOSIS 71 0.0022
268 NEPHROTIC SYNDROME 15 0.0022
269 PROCTITIS 6 0.0021
270 GAMMA-GLUTAMYLTRANSFERASE INCREASED 47 0.0021
271 OXYGEN SATURATION ABNORMAL 6 0.0021
272 PULMONARY TUBERCULOSIS 9 0.0021
273 WHITE BLOOD CELL COUNT DECREASED 228 0.0021
274 TUMOUR HAEMORRHAGE 6 0.0021
275 EOSINOPHIL COUNT DECREASED 5 0.0021
276 LEUKOPENIA 105 0.0021
277 UPPER GASTROINTESTINAL HAEMORRHAGE 35 0.0021
278 ENTEROCOLITIS 12 0.0021
279 LYMPHOMA 32 0.0021
280 NEUTROPHIL COUNT INCREASED 21 0.0020
281 CYTOPENIA 25 0.0020
282 CYTOMEGALOVIRUS VIRAEMIA 9 0.0020
283 THYROIDITIS 6 0.0020
284 OSTEOPOROSIS 82 0.0020
285 HEPATITIS C 24 0.0020
286 HYPERTHERMIA 15 0.0020
287 PULMONARY ALVEOLAR HAEMORRHAGE 11 0.0020
288 CANCER PAIN 5 0.0020
289 LIVER INJURY 48 0.0020
290 FEMORAL NECK FRACTURE 10 0.0019
291 FIBROSIS 6 0.0019
292 THROMBOTIC MICROANGIOPATHY 19 0.0019
293 INTERSTITIAL LUNG DISEASE 94 0.0019
294 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 5 0.0019
295 EUGLYCAEMIC DIABETIC KETOACIDOSIS 8 0.0019
296 POLYNEUROPATHY 23 0.0019
297 APLASTIC ANAEMIA 10 0.0019
298 HEPATOCELLULAR INJURY 27 0.0019
299 HYPERPYREXIA 8 0.0019
300 RENAL CYST 15 0.0019
301 MULTIPLE ORGAN DYSFUNCTION SYNDROME 53 0.0019
302 PROTEIN TOTAL DECREASED 7 0.0019
303 THROMBOCYTOPENIA 207 0.0018
304 PLASMA CELL MYELOMA RECURRENT 6 0.0018
305 HEPATITIS ACUTE 12 0.0018
306 LYMPHOCYTE COUNT INCREASED 6 0.0018
307 HYPOGAMMAGLOBULINAEMIA 12 0.0018
308 ESCHERICHIA INFECTION 15 0.0018
309 ORGANISING PNEUMONIA 9 0.0018
310 HEPATIC CYTOLYSIS 23 0.0018
311 RHINOVIRUS INFECTION 7 0.0018
312 PNEUMONIA FUNGAL 7 0.0018
313 STATUS EPILEPTICUS 20 0.0018
314 ENCEPHALOPATHY 43 0.0017
315 DUODENAL ULCER HAEMORRHAGE 5 0.0017
316 BLOOD MAGNESIUM DECREASED 15 0.0017
317 MALABSORPTION 9 0.0017
318 BONE MARROW FAILURE 35 0.0017
319 ENTERITIS 11 0.0017
320 RECURRENT CANCER 7 0.0017
321 HYPERCALCAEMIA 21 0.0017
322 MYELOSUPPRESSION 61 0.0017
323 HERPES SIMPLEX 11 0.0017
324 HAEMORRHAGE SUBCUTANEOUS 6 0.0017
325 ILEUS 21 0.0017
326 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 10 0.0017
327 NEUTROPENIA 229 0.0017
328 PLEURISY 10 0.0017
329 COMPRESSION FRACTURE 9 0.0017
330 GESTATIONAL DIABETES 8 0.0017
331 BLOOD UREA INCREASED 28 0.0017
332 HUMERUS FRACTURE 8 0.0017
333 METABOLIC ACIDOSIS 52 0.0016
334 ECTOPIC PREGNANCY 5 0.0016
335 LARYNGEAL OEDEMA 10 0.0016
336 BRAIN NATRIURETIC PEPTIDE INCREASED 5 0.0016
337 TOOTH INJURY 7 0.0016
338 ERYTHEMA MULTIFORME 15 0.0016
339 RHABDOMYOLYSIS 67 0.0016
340 FLANK PAIN 15 0.0016
341 DERMATITIS EXFOLIATIVE 8 0.0016
342 ERYSIPELAS 8 0.0016
343 HICCUPS 13 0.0016
344 KLEBSIELLA INFECTION 8 0.0016
345 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 13 0.0016
346 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 15 0.0016
347 GASTRIC HAEMORRHAGE 18 0.0016
348 EOSINOPHIL COUNT INCREASED 13 0.0016
349 DUODENAL ULCER 11 0.0016
350 LIVE BIRTH 13 0.0016
351 SUSPECTED OFF LABEL USE 7 0.0015
352 VASCULITIS 18 0.0015
353 HYPERKALAEMIA 54 0.0015
354 MATERNAL EXPOSURE DURING PREGNANCY 137 0.0015
355 HEPATOMEGALY 15 0.0015
356 SERUM FERRITIN INCREASED 8 0.0015
357 LOCALISED OEDEMA 7 0.0015
358 ANURIA 13 0.0015
359 CYTOLYTIC HEPATITIS 5 0.0015
360 ATRIOVENTRICULAR BLOCK COMPLETE 10 0.0015
361 DISSEMINATED INTRAVASCULAR COAGULATION 21 0.0015
362 GINGIVITIS 8 0.0015
363 INGUINAL HERNIA 9 0.0015
364 CHRONIC LYMPHOCYTIC LEUKAEMIA 7 0.0015
365 PANCREATITIS ACUTE 33 0.0015
366 DRUG ERUPTION 26 0.0015
367 DEMYELINATION 6 0.0015
368 CHROMATURIA 33 0.0015
369 PLASMA CELL MYELOMA 57 0.0015
370 CAESAREAN SECTION 17 0.0015
371 CHOLANGITIS 9 0.0015
372 MYOSITIS 13 0.0014
373 BLOOD CREATININE ABNORMAL 5 0.0014
374 VENTRICULAR FIBRILLATION 16 0.0014
375 ACIDOSIS 11 0.0014
376 RASH MACULO-PAPULAR 32 0.0014
377 HYPOMAGNESAEMIA 20 0.0014
378 RENAL CELL CARCINOMA 7 0.0014
379 CHOLECYSTITIS 17 0.0014
380 STAPHYLOCOCCAL SEPSIS 7 0.0014
381 SEPSIS 158 0.0014
382 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 11 0.0014
383 PERIORBITAL SWELLING 8 0.0014
384 SINUS TACHYCARDIA 20 0.0014
385 GRANULOCYTOPENIA 8 0.0014
386 PSEUDOMONAS INFECTION 12 0.0014
387 ACUTE KIDNEY INJURY 214 0.0014
388 TACHYPNOEA 19 0.0014
389 GRAFT VERSUS HOST DISEASE 10 0.0014
390 HEPATIC LESION 6 0.0014
391 BLOOD PRESSURE SYSTOLIC INCREASED 27 0.0014
392 OSTEOPENIA 21 0.0014
393 SQUAMOUS CELL CARCINOMA 13 0.0014
394 AMMONIA INCREASED 7 0.0014
395 ASPERGILLUS INFECTION 9 0.0014
396 CACHEXIA 7 0.0014
397 FOETAL DEATH 7 0.0013
398 TRANSFUSION 14 0.0013
399 HYDRONEPHROSIS 10 0.0013
400 HEPATITIS CHOLESTATIC 8 0.0013
401 GASTRIC ULCER 25 0.0013
402 HAEMATOCRIT DECREASED 26 0.0013
403 DISEASE COMPLICATION 6 0.0013
404 LUMBAR VERTEBRAL FRACTURE 6 0.0013
405 HYPERTRANSAMINASAEMIA 9 0.0013
406 ELECTROLYTE IMBALANCE 15 0.0013
407 OLIGURIA 8 0.0013
408 RENAL DISORDER 60 0.0013
409 GASTRITIS EROSIVE 6 0.0013
410 PLEURAL EFFUSION 78 0.0013
411 MULTI-ORGAN FAILURE 22 0.0013
412 URINE OUTPUT DECREASED 11 0.0013
413 HEPATOTOXICITY 28 0.0013
414 AZOTAEMIA 5 0.0013
415 HYPOXIA 44 0.0012
416 ANAEMIA 238 0.0012
417 ACUTE RESPIRATORY FAILURE 24 0.0012
418 TENDERNESS 13 0.0012
419 BLOOD CALCIUM DECREASED 14 0.0012
420 ACUTE RESPIRATORY DISTRESS SYNDROME 22 0.0012
421 STILLBIRTH 6 0.0012
422 CHOLECYSTITIS ACUTE 7 0.0012
423 HEPATIC STEATOSIS 23 0.0012
424 VITAMIN D DEFICIENCY 12 0.0012
425 CEREBRAL INFARCTION 30 0.0012
426 RENAL FAILURE 163 0.0012
427 LUNG INFECTION 19 0.0012
428 MULTIPLE FRACTURES 20 0.0012
429 RENAL INJURY 36 0.0012
430 COLON CANCER 18 0.0012
431 HYPERNATRAEMIA 6 0.0012
432 LIVER FUNCTION TEST ABNORMAL 35 0.0012
433 HEPATIC ENZYME ABNORMAL 6 0.0012
434 LYMPHOPENIA 17 0.0012
435 CONGESTIVE CARDIOMYOPATHY 5 0.0012
436 HYPERTRIGLYCERIDAEMIA 7 0.0012
437 BONE PAIN 70 0.0012
438 PEMPHIGOID 9 0.0012
439 C-REACTIVE PROTEIN INCREASED 43 0.0012
440 MELAENA 26 0.0012
441 ENDOCARDITIS 6 0.0012
442 CEREBRAL ISCHAEMIA 6 0.0012
443 MALNUTRITION 13 0.0012
444 ALTERED STATE OF CONSCIOUSNESS 25 0.0012
445 RESPIRATORY SYNCYTIAL VIRUS INFECTION 10 0.0011
446 WHITE BLOOD CELL COUNT INCREASED 44 0.0011
447 DIVERTICULUM INTESTINAL 5 0.0011
448 PERICARDIAL EFFUSION 26 0.0011
449 ANAL FISTULA 6 0.0011
450 ABORTION SPONTANEOUS 45 0.0011
451 RENAL TUBULAR NECROSIS 11 0.0011
452 EPSTEIN-BARR VIRUS INFECTION 7 0.0011
453 GASTROINTESTINAL INFECTION 10 0.0011
454 FRACTURE 21 0.0011
455 COLITIS 42 0.0011
456 HAEMATEMESIS 28 0.0011
457 GASTROENTERITIS 16 0.0011
458 PANCYTOPENIA 61 0.0011
459 HYPERLIPIDAEMIA 13 0.0011
460 CARDIAC FAILURE 87 0.0011
461 EYELID PTOSIS 11 0.0011
462 ARTHRITIS INFECTIVE 5 0.0011
463 NECROSIS 6 0.0011
464 PYREXIA 372 0.0011
465 HAEMODIALYSIS 9 0.0011
466 ADRENAL INSUFFICIENCY 13 0.0011
467 HYPERGLYCAEMIA 39 0.0011
468 ANHEDONIA 28 0.0011
469 HEPATIC ENZYME INCREASED 72 0.0011
470 FACIAL PARALYSIS 9 0.0011
471 PETECHIAE 11 0.0011
472 HAEMATOTOXICITY 10 0.0011
473 CARDIAC TAMPONADE 5 0.0011
474 HYPERTONIA 6 0.0010
475 HYPONATRAEMIA 59 0.0010
476 RESPIRATORY FAILURE 76 0.0010
477 HERPES VIRUS INFECTION 6 0.0010
478 GASTROINTESTINAL TOXICITY 5 0.0010
479 CHRONIC KIDNEY DISEASE 79 0.0010
480 CLOSTRIDIUM DIFFICILE COLITIS 11 0.0010
481 ENTEROCOCCAL INFECTION 5 0.0010
482 DRUG LEVEL INCREASED 17 0.0010
483 PERIPHERAL SENSORY NEUROPATHY 6 0.0010
484 GINGIVAL BLEEDING 14 0.0010
485 MATERNAL EXPOSURE BEFORE PREGNANCY 7 0.0010
486 TREATMENT NONCOMPLIANCE 56 0.0010
487 COAGULOPATHY 17 0.0010
488 ANEURYSM 5 0.0010
489 PROTHROMBIN TIME PROLONGED 6 0.0010
490 ATRIAL FLUTTER 8 0.0010
491 PERITONITIS BACTERIAL 10 0.0010
492 DERMATITIS ACNEIFORM 6 0.0010
493 RETINAL HAEMORRHAGE 7 0.0010
494 SHOCK HAEMORRHAGIC 8 0.0010
495 SOPOR 13 0.0010
496 SUBDURAL HAEMATOMA 14 0.0010
497 IRON DEFICIENCY ANAEMIA 9 0.0010
498 GENERALISED OEDEMA 12 0.0010
499 MYOCARDITIS 11 0.0010
500 PNEUMONITIS 26 0.0010
501 PNEUMONIA 309 0.0010
502 EYELID OEDEMA 11 0.0009
503 PULMONARY MASS 14 0.0009
504 NEOPLASM MALIGNANT 62 0.0009
505 ANAL ABSCESS 5 0.0009
506 BONE DENSITY DECREASED 29 0.0009
507 CHEILITIS 5 0.0009
508 ECONOMIC PROBLEM 14 0.0009
509 TOXIC EPIDERMAL NECROLYSIS 14 0.0009
510 GASTROINTESTINAL HAEMORRHAGE 77 0.0009
511 RENAL FAILURE ACUTE 39 0.0009
512 PROCEDURAL COMPLICATION 7 0.0009
513 RED BLOOD CELL COUNT DECREASED 26 0.0009
514 TUBULOINTERSTITIAL NEPHRITIS 17 0.0009
515 HAEMOLYSIS 7 0.0009
516 HAEMOGLOBIN DECREASED 93 0.0009
517 LUNG INFILTRATION 8 0.0009
518 DECREASED APPETITE 210 0.0009
519 PREGNANCY 18 0.0009
520 CEREBRAL HAEMORRHAGE 32 0.0009
521 ACUTE PULMONARY OEDEMA 5 0.0009
522 PANCREATITIS 47 0.0009
523 METASTASES TO LYMPH NODES 6 0.0009
524 SUBARACHNOID HAEMORRHAGE 9 0.0009
525 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 9 0.0009
526 NEUROPATHY PERIPHERAL 83 0.0009
527 ONYCHOCLASIS 6 0.0009
528 NEOPLASM 10 0.0009
529 LARGE INTESTINE POLYP 6 0.0009
530 HYPOPHAGIA 22 0.0009
531 NEPHROPATHY 8 0.0009
532 NEUROTOXICITY 15 0.0009
533 SPINAL PAIN 10 0.0009
534 METASTASES TO BONE 14 0.0009
535 HERPES ZOSTER 49 0.0009
536 VENTRICULAR TACHYCARDIA 14 0.0008
537 LEUKAEMIA 8 0.0008
538 DEVICE RELATED INFECTION 13 0.0008
539 HOSPITALISATION 129 0.0008
540 DISEASE PROGRESSION 99 0.0008
541 DERMATITIS BULLOUS 6 0.0008
542 MENTAL STATUS CHANGES 23 0.0008
543 HAEMOPTYSIS 23 0.0008
544 PARKINSONISM 8 0.0008
545 PNEUMOTHORAX 13 0.0008
546 DRUG INTERACTION 130 0.0008
547 MOUTH HAEMORRHAGE 6 0.0008
548 HAEMATURIA 28 0.0008
549 PREMATURE DELIVERY 13 0.0008
550 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 21 0.0008
551 CONCOMITANT DISEASE AGGRAVATED 5 0.0008
552 RESPIRATORY TRACT INFECTION 21 0.0008
553 PERIPHERAL COLDNESS 11 0.0008
554 SPINAL FRACTURE 16 0.0008
555 GASTRITIS 21 0.0008
556 SPINAL OSTEOARTHRITIS 7 0.0008
557 DERMATITIS ALLERGIC 10 0.0008
558 IMMUNOSUPPRESSION 7 0.0008
559 EMPHYSEMA 8 0.0008
560 STOMATITIS 48 0.0008
561 LYMPHADENOPATHY 28 0.0008
562 BODY TEMPERATURE INCREASED 16 0.0008
563 HYPOTHYROIDISM 25 0.0008
564 GOUT 14 0.0008
565 HELICOBACTER INFECTION 8 0.0008
566 RIB FRACTURE 16 0.0008
567 DIALYSIS 11 0.0008
568 PERITONITIS 16 0.0008
569 CANDIDA INFECTION 13 0.0008
570 ANGINA UNSTABLE 5 0.0008
571 END STAGE RENAL DISEASE 14 0.0008
572 PLATELET COUNT INCREASED 10 0.0008
573 MALIGNANT NEOPLASM PROGRESSION 78 0.0008
574 INCORRECT PRODUCT STORAGE 10 0.0008
575 HYPERTHYROIDISM 11 0.0008
576 ABDOMINAL DISTENSION 79 0.0008
577 FULL BLOOD COUNT ABNORMAL 8 0.0008
578 LOW BIRTH WEIGHT BABY 6 0.0008
579 APPENDICITIS 7 0.0007
580 BLOOD DISORDER 6 0.0007
581 MYASTHENIA GRAVIS 6 0.0007
582 TASTE DISORDER 15 0.0007
583 BLOOD POTASSIUM INCREASED 12 0.0007
584 DECUBITUS ULCER 6 0.0007
585 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
586 SMALL INTESTINAL OBSTRUCTION 9 0.0007
587 LOWER LIMB FRACTURE 14 0.0007
588 SPINAL COMPRESSION FRACTURE 6 0.0007
589 PHARYNGITIS 9 0.0007
590 ACUTE CORONARY SYNDROME 6 0.0007
591 ENCEPHALITIS 5 0.0007
592 MUSCULOSKELETAL CHEST PAIN 11 0.0007
593 THERAPY PARTIAL RESPONDER 11 0.0007
594 FOETAL EXPOSURE DURING PREGNANCY 57 0.0007
595 BLOOD POTASSIUM DECREASED 21 0.0007
596 DELIRIUM 24 0.0007
597 MYELODYSPLASTIC SYNDROME 10 0.0007
598 DEAFNESS 18 0.0007
599 TREATMENT FAILURE 57 0.0007
600 EPILEPSY 21 0.0007
601 DYSPHAGIA 65 0.0007
602 CHILLS 80 0.0007
603 DIABETES MELLITUS 52 0.0007
604 PRODUCT COMMUNICATION ISSUE 6 0.0007
605 PURPURA 6 0.0007
606 ISCHAEMIC STROKE 12 0.0007
607 INFECTION 97 0.0007
608 ERECTILE DYSFUNCTION 17 0.0007
609 SUDDEN DEATH 7 0.0007
610 NO THERAPEUTIC RESPONSE 8 0.0007
611 PERICARDITIS 11 0.0007
612 SHOCK 15 0.0007
613 RESPIRATORY DISTRESS 18 0.0007
614 LIVER FUNCTION TEST INCREASED 14 0.0007
615 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
616 ATRIOVENTRICULAR BLOCK 5 0.0006
617 DEMENTIA 18 0.0006
618 DEATH 554 0.0006
619 FEEDING DISORDER 13 0.0006
620 BASAL CELL CARCINOMA 10 0.0006
621 OESOPHAGITIS 7 0.0006
622 INTENTIONAL PRODUCT USE ISSUE 56 0.0006
623 BLINDNESS UNILATERAL 9 0.0006
624 ARRHYTHMIA 30 0.0006
625 FOOT FRACTURE 12 0.0006
626 OFF LABEL USE 553 0.0006
627 UPPER RESPIRATORY TRACT INFECTION 29 0.0006
628 RASH PRURITIC 34 0.0006
629 CARDIOGENIC SHOCK 9 0.0006
630 SKIN INFECTION 7 0.0006
631 GENERAL PHYSICAL HEALTH DETERIORATION 72 0.0006
632 HYPERCHOLESTEROLAEMIA 6 0.0006
633 DERMATITIS 13 0.0006
634 MOUTH ULCERATION 13 0.0006
635 ATRIAL FIBRILLATION 60 0.0006
636 COVID-19 108 0.0006
637 HAEMORRHOIDS 12 0.0006
638 ELECTROCARDIOGRAM QT PROLONGED 22 0.0006
639 INTESTINAL OBSTRUCTION 23 0.0006
640 CHOLELITHIASIS 20 0.0006
641 DISEASE RECURRENCE 29 0.0006
642 OEDEMA 33 0.0006
643 ASTHENIA 228 0.0006
644 INABILITY TO AFFORD MEDICATION 6 0.0006
645 DIARRHOEA 389 0.0006
646 EPISTAXIS 45 0.0006
647 BONE LOSS 9 0.0006
648 DYSURIA 22 0.0006
649 TOXIC SKIN ERUPTION 6 0.0006
650 MYALGIA 101 0.0006
651 FACE OEDEMA 10 0.0006
652 DRUG DOSE OMISSION 98 0.0006
653 ABDOMINAL PAIN UPPER 122 0.0006
654 LUNG DISORDER 29 0.0006
655 STEVENS-JOHNSON SYNDROME 13 0.0006
656 OEDEMA PERIPHERAL 71 0.0006
657 ACUTE MYOCARDIAL INFARCTION 17 0.0006
658 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 41 0.0006
659 PULMONARY FIBROSIS 11 0.0006
660 MUSCLE SPASTICITY 7 0.0006
661 BLOOD TEST ABNORMAL 8 0.0006
662 SPINAL OPERATION 7 0.0006
663 TENDON RUPTURE 7 0.0006
664 ADVERSE EVENT 52 0.0006
665 EATING DISORDER 12 0.0006
666 HYPERTENSION 119 0.0006
667 HAEMATOCHEZIA 31 0.0006
668 ANGINA PECTORIS 16 0.0006
669 PULMONARY OEDEMA 25 0.0006
670 POOR QUALITY SLEEP 12 0.0006
671 DECREASED ACTIVITY 6 0.0006
672 MUSCULAR WEAKNESS 63 0.0006
673 LEUKOCYTOSIS 10 0.0006
674 MUSCLE ATROPHY 7 0.0006
675 PRODUCT PRESCRIBING ISSUE 12 0.0006
676 FULL BLOOD COUNT DECREASED 11 0.0005
677 SURGERY 32 0.0005
678 THERAPEUTIC RESPONSE DECREASED 33 0.0005
679 RED BLOOD CELL SEDIMENTATION RATE INCREASED 6 0.0005
680 FUNGAL INFECTION 18 0.0005
681 IMMUNODEFICIENCY 8 0.0005
682 BACTERIAL INFECTION 10 0.0005
683 CELLULITIS 27 0.0005
684 MUCOSAL INFLAMMATION 14 0.0005
685 MYOCARDIAL ISCHAEMIA 6 0.0005
686 ABDOMINAL PAIN 122 0.0005
687 NEPHROLITHIASIS 24 0.0005
688 PNEUMONIA ASPIRATION 13 0.0005
689 CONDITION AGGRAVATED 158 0.0005
690 ATELECTASIS 5 0.0005
691 BACK PAIN 120 0.0005
692 COGNITIVE DISORDER 24 0.0005
693 CONSTIPATION 112 0.0005
694 ACUTE MYELOID LEUKAEMIA 8 0.0005
695 GASTRIC CANCER 13 0.0005
696 SKIN FISSURES 10 0.0005
697 URINARY TRACT INFECTION 87 0.0005
698 DECREASED IMMUNE RESPONSIVENESS 5 0.0005
699 DIABETES MELLITUS INADEQUATE CONTROL 9 0.0005
700 COMA 24 0.0005
701 CLOSTRIDIUM DIFFICILE INFECTION 11 0.0005
702 THERAPY INTERRUPTED 36 0.0005
703 INTERVERTEBRAL DISC PROTRUSION 11 0.0005
704 FEELING COLD 14 0.0005
705 DEHYDRATION 67 0.0005
706 ABSCESS 8 0.0005
707 PREMATURE BABY 15 0.0005
708 TACHYCARDIA 44 0.0005
709 INTENTIONAL DOSE OMISSION 14 0.0005
710 THERAPY NON-RESPONDER 22 0.0005
711 HYPOTENSION 98 0.0005
712 CONTUSION 47 0.0005
713 OSTEONECROSIS 16 0.0005
714 FEMUR FRACTURE 15 0.0005
715 INFLUENZA 54 0.0005
716 FREQUENT BOWEL MOVEMENTS 13 0.0005
717 TYPE 2 DIABETES MELLITUS 16 0.0005
718 LABORATORY TEST ABNORMAL 14 0.0005
719 FATIGUE 369 0.0005
720 CATARACT 28 0.0005
721 CIRCULATORY COLLAPSE 8 0.0005
722 BODY HEIGHT DECREASED 5 0.0005
723 HAEMATOMA 12 0.0005
724 OXYGEN SATURATION DECREASED 26 0.0005
725 CONTRAINDICATED PRODUCT ADMINISTERED 14 0.0005
726 NEOPLASM PROGRESSION 16 0.0005
727 PRODUCT USE IN UNAPPROVED INDICATION 114 0.0005
728 BLOOD PRESSURE INCREASED 70 0.0005
729 ASPIRATION 5 0.0005
730 BLOOD GLUCOSE FLUCTUATION 5 0.0005
731 ORAL CANDIDIASIS 6 0.0005
732 IMMUNE SYSTEM DISORDER 6 0.0005
733 METASTASES TO LIVER 8 0.0005
734 WEIGHT DECREASED 127 0.0005
735 CARDIO-RESPIRATORY ARREST 19 0.0005
736 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
737 UPPER LIMB FRACTURE 9 0.0005
738 SKIN DISORDER 15 0.0004
739 GALLBLADDER DISORDER 8 0.0004
740 TOOTHACHE 8 0.0004
741 INFUSION RELATED REACTION 29 0.0004
742 BLOOD PRESSURE DECREASED 29 0.0004
743 RASH 190 0.0004
744 GLYCOSYLATED HAEMOGLOBIN INCREASED 11 0.0004
745 RESPIRATORY DISORDER 13 0.0004
746 POLLAKIURIA 18 0.0004
747 DEPRESSED LEVEL OF CONSCIOUSNESS 17 0.0004
748 DEVICE OCCLUSION 6 0.0004
749 BLOOD SODIUM DECREASED 8 0.0004
750 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
751 HYPOAESTHESIA 63 0.0004
752 HAEMORRHAGE 44 0.0004
753 NAUSEA 328 0.0004
754 LUNG NEOPLASM MALIGNANT 17 0.0004
755 PRESCRIBED OVERDOSE 8 0.0004
756 MALAISE 181 0.0004
757 CARDIAC ARREST 34 0.0004
758 PULMONARY EMBOLISM 39 0.0004
759 ACCIDENTAL OVERDOSE 15 0.0004
760 MUSCULOSKELETAL DISCOMFORT 7 0.0004
761 TOOTH DISORDER 9 0.0004
762 OSTEONECROSIS OF JAW 10 0.0004
763 DYSPNOEA EXERTIONAL 15 0.0004
764 HYPOGLYCAEMIA 19 0.0004
765 MENTAL DISORDER 17 0.0004
766 PHARYNGEAL OEDEMA 6 0.0004
767 URINARY RETENTION 13 0.0004
768 FLATULENCE 22 0.0004
769 NERVOUS SYSTEM DISORDER 12 0.0004
770 PERIPHERAL SWELLING 59 0.0004
771 GAIT DISTURBANCE 73 0.0004
772 INSOMNIA 101 0.0004
773 HEAD INJURY 12 0.0004
774 MOBILITY DECREASED 27 0.0004
775 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 11 0.0004
776 NEURALGIA 9 0.0004
777 POST PROCEDURAL COMPLICATION 7 0.0004
778 STAPHYLOCOCCAL INFECTION 12 0.0004
779 ABDOMINAL DISCOMFORT 61 0.0004
780 ALOPECIA 71 0.0004
781 CARDIAC FAILURE CONGESTIVE 29 0.0004
782 VOMITING 168 0.0004
783 HEMIPARESIS 6 0.0004
784 EXPOSURE DURING PREGNANCY 22 0.0004
785 DISORIENTATION 14 0.0004
786 CHEST PAIN 65 0.0004
787 PRESCRIBED UNDERDOSE 7 0.0004
788 THERAPY CESSATION 18 0.0004
789 HYPOACUSIS 15 0.0003
790 THROMBOSIS 28 0.0003
791 INTENTIONAL SELF-INJURY 7 0.0003
792 DIPLOPIA 9 0.0003
793 CYSTITIS 11 0.0003
794 ORTHOSTATIC HYPOTENSION 6 0.0003
795 SKIN EXFOLIATION 29 0.0003
796 PRODUCT STORAGE ERROR 30 0.0003
797 DRUG INEFFECTIVE 451 0.0003
798 COUGH 95 0.0003
799 DEEP VEIN THROMBOSIS 22 0.0003
800 BLISTER 19 0.0003
801 BRONCHITIS 25 0.0003
802 PULMONARY HYPERTENSION 7 0.0003
803 THIRST 6 0.0003
804 DYSPNOEA 190 0.0003
805 ROAD TRAFFIC ACCIDENT 14 0.0003
806 PALPITATIONS 39 0.0003
807 GASTROENTERITIS VIRAL 6 0.0003
808 OSTEOMYELITIS 6 0.0003
809 LIMB INJURY 9 0.0003
810 CEREBROVASCULAR ACCIDENT 56 0.0003
811 ARTHRITIS 26 0.0003
812 WRONG TECHNIQUE IN DRUG USAGE PROCESS 12 0.0003
813 MENTAL IMPAIRMENT 8 0.0003
814 BLOOD COUNT ABNORMAL 5 0.0003
815 INFLAMMATION 17 0.0003
816 SKIN LESION 9 0.0003
817 VISION BLURRED 45 0.0003
818 TREMOR 54 0.0003
819 DIVERTICULITIS 9 0.0003
820 OROPHARYNGEAL PAIN 30 0.0003
821 GASTROINTESTINAL DISORDER 29 0.0003
822 ANKLE FRACTURE 5 0.0003
823 FAECES DISCOLOURED 7 0.0003
824 ARTHRALGIA 134 0.0003
825 MUSCLE SPASMS 59 0.0003
826 FALL 107 0.0003
827 BRAIN FOG 5 0.0003
828 DIZZINESS 158 0.0003
829 RASH MACULAR 11 0.0003
830 HEART RATE DECREASED 11 0.0003
831 LETHARGY 18 0.0003
832 PRODUCT SUBSTITUTION ISSUE 18 0.0003
833 HEADACHE 196 0.0003
834 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 15 0.0003
835 LOSS OF CONSCIOUSNESS 40 0.0003
836 PANCREATIC CARCINOMA 9 0.0003
837 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17 0.0003
838 DYSSTASIA 9 0.0003
839 ORAL HERPES 6 0.0003
840 PAIN IN EXTREMITY 90 0.0003
841 SKIN DISCOLOURATION 14 0.0003
842 UNEVALUABLE EVENT 23 0.0003
843 HEART RATE INCREASED 30 0.0003
844 CHEST DISCOMFORT 31 0.0003
845 VISUAL ACUITY REDUCED 10 0.0003
846 PRURITUS 115 0.0003
847 DISCOMFORT 18 0.0003
848 HYPERHIDROSIS 38 0.0003
849 ANGIOEDEMA 13 0.0003
850 MOOD ALTERED 8 0.0003
851 PRODUCTIVE COUGH 14 0.0003
852 LIMB DISCOMFORT 9 0.0003
853 RESPIRATORY ARREST 8 0.0003
854 EMOTIONAL DISTRESS 35 0.0003
855 CARDIAC DISORDER 27 0.0003
856 PAIN IN JAW 8 0.0003
857 AGEUSIA 7 0.0003
858 MOVEMENT DISORDER 9 0.0003
859 VERTIGO 17 0.0003
860 SWELLING 26 0.0003
861 SEIZURE 32 0.0003
862 PRODUCT DOSE OMISSION 18 0.0003
863 FLUID RETENTION 14 0.0003
864 DYSPEPSIA 27 0.0003
865 BONE DISORDER 5 0.0003
866 ANAPHYLACTIC SHOCK 7 0.0003
867 PRODUCT USE ISSUE 51 0.0003
868 SKIN ULCER 7 0.0003
869 NO ADVERSE EVENT 49 0.0003
870 EYE SWELLING 10 0.0003
871 NECK PAIN 15 0.0003
872 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 14 0.0003
873 PAIN 164 0.0003
874 TOXICITY TO VARIOUS AGENTS 45 0.0003
875 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
876 CORONARY ARTERY DISEASE 8 0.0003
877 BLOOD URINE PRESENT 5 0.0003
878 EAR INFECTION 7 0.0003
879 AMNESIA 17 0.0003
880 SWELLING FACE 17 0.0003
881 GASTROOESOPHAGEAL REFLUX DISEASE 21 0.0003
882 DRY MOUTH 21 0.0003
883 DRUG INTOLERANCE 25 0.0003
884 DEPRESSION 58 0.0003
885 MYOCARDIAL INFARCTION 44 0.0003
886 HALLUCINATION 19 0.0003
887 MEDICATION ERROR 14 0.0003
888 URTICARIA 42 0.0003
889 SOMNOLENCE 50 0.0002
890 MUSCULOSKELETAL PAIN 13 0.0002
891 EYE PAIN 14 0.0002
892 SPEECH DISORDER 13 0.0002
893 PRESYNCOPE 6 0.0002
894 BLINDNESS 10 0.0002
895 BRADYCARDIA 13 0.0002
896 BALANCE DISORDER 21 0.0002
897 ABASIA 6 0.0002
898 DRY EYE 12 0.0002
899 WEIGHT INCREASED 53 0.0002
900 URINARY INCONTINENCE 7 0.0002
901 CONFUSIONAL STATE 38 0.0002
902 ARTHROPATHY 13 0.0002
903 GASTRIC DISORDER 8 0.0002
904 RECTAL HAEMORRHAGE 10 0.0002
905 LACRIMATION INCREASED 7 0.0002
906 ECZEMA 12 0.0002
907 ANXIETY 65 0.0002
908 PAIN OF SKIN 6 0.0002
909 PALLOR 6 0.0002
910 ERYTHEMA 45 0.0002
911 BLOOD GLUCOSE INCREASED 41 0.0002
912 DRY SKIN 29 0.0002
913 PARAESTHESIA 34 0.0002
914 SLEEP DISORDER 15 0.0002
915 OSTEOARTHRITIS 9 0.0002
916 SYNCOPE 21 0.0002
917 GAIT INABILITY 7 0.0002
918 DIABETIC KETOACIDOSIS 5 0.0002
919 ANGER 7 0.0002
920 DYSPHONIA 12 0.0002
921 ADVERSE DRUG REACTION 18 0.0002
922 PROSTATE CANCER 16 0.0002
923 PANIC ATTACK 7 0.0002
924 HIP FRACTURE 6 0.0002
925 NIGHT SWEATS 6 0.0002
926 RHINORRHOEA 12 0.0002
927 NASOPHARYNGITIS 34 0.0002
928 PRODUCT DOSE OMISSION ISSUE 54 0.0002
929 HYPERSENSITIVITY 34 0.0002
930 INTENTIONAL PRODUCT MISUSE 16 0.0002
931 EYE DISORDER 6 0.0002
932 FEELING HOT 11 0.0002
933 ABNORMAL BEHAVIOUR 7 0.0002
934 SINUSITIS 18 0.0002
935 MEMORY IMPAIRMENT 24 0.0002
936 JOINT SWELLING 21 0.0002
937 ACNE 13 0.0002
938 NASAL CONGESTION 10 0.0002
939 OVERDOSE 36 0.0002
940 APHASIA 5 0.0002
941 SUICIDE ATTEMPT 10 0.0002
942 DRUG ADMINISTRATION ERROR 5 0.0002
943 BREAST CANCER 15 0.0002
944 CONVULSION 9 0.0002
945 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
946 UNDERDOSE 11 0.0002
947 DYSGEUSIA 11 0.0001
948 FLUSHING 15 0.0001
949 DRUG EXPOSURE DURING PREGNANCY 5 0.0001
950 ANAPHYLACTIC REACTION 8 0.0001
951 BURNING SENSATION 10 0.0001
952 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 25 0.0001
953 VAGINAL HAEMORRHAGE 6 0.0001
954 WHEEZING 8 0.0001
955 NERVOUSNESS 7 0.0001
956 FEELING ABNORMAL 32 0.0001
957 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 27 0.0001
958 DYSARTHRIA 5 0.0001
959 ASTHMA 15 0.0001
960 HOT FLUSH 10 0.0001
961 DEPRESSED MOOD 7 0.0001
962 TINNITUS 6 0.0001
963 VISUAL IMPAIRMENT 16 0.0001
964 BLOOD CHOLESTEROL INCREASED 6 0.0001
965 OCULAR HYPERAEMIA 6 0.0001
966 ILLNESS 13 0.0001
967 RASH ERYTHEMATOUS 6 0.0001
968 DYSKINESIA 5 0.0001
969 SUICIDAL IDEATION 11 0.0001
970 DRUG ABUSE 10 0.0001
971 AGGRESSION 6 0.0001
972 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
973 MUSCULOSKELETAL STIFFNESS 10 0.0001
974 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
975 COLITIS ULCERATIVE 5 0.0001
976 PRODUCT QUALITY ISSUE 15 0.0001
977 INFLUENZA LIKE ILLNESS 9 0.0001
978 AGITATION 8 0.0001
979 PSORIASIS 14 0.0001
980 EYE IRRITATION 6 0.0001
981 SKIN BURNING SENSATION 7 0.0001
982 RHEUMATOID ARTHRITIS 11 0.0001
983 DRUG EFFECT DECREASED 5 0.0001
984 DEVICE MALFUNCTION 6 0.0001
985 MIGRAINE 8 0.0001
986 DEVICE ISSUE 6 0.0001
987 INCORRECT DOSE ADMINISTERED 15 0.0001
988 INJECTION SITE ERYTHEMA 7 0.0001
989 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
990 INJECTION SITE PAIN 10 0.0000